An M Van Berendoncks
Overview
Explore the profile of An M Van Berendoncks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Van Berendoncks A, Garnier A, Ventura-Clapier R, Conraads V
Heart Fail Rev
. 2012 Oct;
18(5):557-66.
PMID: 23090715
The concept of skeletal muscle myopathy as a main determinant of exercise intolerance in chronic heart failure (HF) is gaining acceptance. Symptoms that typify HF patients, including shortness of breath...
12.
Conraads V, Van Craenenbroeck E, De Maeyer C, Van Berendoncks A, Beckers P, Vrints C
Heart Fail Rev
. 2012 Jun;
18(1):65-77.
PMID: 22684340
Despite remarkable progress in the therapeutic approach of patients with chronic heart failure (CHF), exercise intolerance remains one of the hallmarks of the disease. During the past two decades, evidence...
13.
Van Berendoncks A, Coenen S, Elseviers M, Conraads V
Int J Cardiol
. 2012 Feb;
156(2):214.
PMID: 22336248
No abstract available.
14.
Beckers P, Possemiers N, Van Craenenbroeck E, Van Berendoncks A, Wuyts K, Vrints C, et al.
Am J Phys Med Rehabil
. 2012 Jan;
91(2):148-55.
PMID: 22248807
Objective: Exercise training efficiently improves peak oxygen uptake (V˙O2peak) in patients with chronic heart failure. To optimize training-derived benefit, higher exercise intensities are being explored. The correct identification of anaerobic...
15.
Van Berendoncks A, Garnier A, Beckers P, Hoymans V, Possemiers N, Fortin D, et al.
Heart
. 2011 Jun;
97(17):1403-9.
PMID: 21685184
Background: Resistance to the insulin-sensitising adipocytokine, adiponectin, has been described at the level of the skeletal muscle in patients with chronic heart failure (CHF). Objective: To investigate whether exercise training...
16.
Beckers P, Possemiers N, Van Craenenbroeck E, Van Berendoncks A, Wuyts K, Vrints C, et al.
Eur J Prev Cardiol
. 2011 Apr;
19(3):389-95.
PMID: 21450577
Aim: To verify the impact of testing mode on maximal, sub-maximal parameters and on cardiopulmonary exercise test (CPET) derived prognostic markers in patients with chronic heart failure (CHF). Method: 55...
17.
Van Berendoncks A, Conraads V
Curr Heart Fail Rep
. 2011 Mar;
8(2):113-22.
PMID: 21424675
The contribution of skeletal muscle myopathy to the phenotype of patients with chronic heart failure (CHF) has become generally accepted. Besides the macro- and microscopic changes that develop during the...
18.
Van Berendoncks A, Conraads V, Van Leuven W, Van Hoof V, De Wilde S, Vrints C, et al.
J Immunol Methods
. 2010 Sep;
362(1-2):209-12.
PMID: 20833174
Adiponectin is an insulin-sensitizing adipocytokine that circulates in plasma as multimeric isoforms, including trimers, hexamers and high molecular weight complexes. Although adiponectin multimers have previously been measured by Western blot,...
19.
Van Berendoncks A, Elseviers M, Lins R
Clin J Am Soc Nephrol
. 2010 Jul;
5(10):1755-62.
PMID: 20634328
Background And Objectives: The multicenter Stuivenberg Hospital Acute Renal Failure 4 study investigated outcome in patients with acute kidney injury (AKI) stratified according to disease severity by the Stuivenberg Hospital...
20.
Van Berendoncks A, Beckers P, Hoymans V, Possemiers N, Coenen S, Elseviers M, et al.
Int J Cardiol
. 2010 May;
150(3):296-300.
PMID: 20488568
Background: Recent evidence suggests that high adiponectin levels serve as an independent predictor of mortality in chronic heart failure (CHF) patients. We aimed to assess the prognostic importance of adiponectin...